Cargando…
Mucosal cell populations may contribute to peripheral immune abnormalities in HIV-infected subjects introducing cART with moderate immune-suppression
HIV infection causes the progressive depletion of CD4+ T-lymphocytes and profound modifications of T-cell homeostasis, which persist despite virologically-suppressive treatment and have been linked to a worse clinical outcome. Enduring alterations of the gastrointestinal tract may represent the unde...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375585/ https://www.ncbi.nlm.nih.gov/pubmed/30763359 http://dx.doi.org/10.1371/journal.pone.0212075 |
_version_ | 1783395386605436928 |
---|---|
author | Basilissi, Matteo Tincati, Camilla Merlini, Esther Ancona, Giuseppe Borghi, Elisa Borgo, Francesca Barassi, Alessandra d’Arminio Monforte, Antonella Marchetti, Giulia |
author_facet | Basilissi, Matteo Tincati, Camilla Merlini, Esther Ancona, Giuseppe Borghi, Elisa Borgo, Francesca Barassi, Alessandra d’Arminio Monforte, Antonella Marchetti, Giulia |
author_sort | Basilissi, Matteo |
collection | PubMed |
description | HIV infection causes the progressive depletion of CD4+ T-lymphocytes and profound modifications of T-cell homeostasis, which persist despite virologically-suppressive treatment and have been linked to a worse clinical outcome. Enduring alterations of the gastrointestinal tract may represent the underlying pathogenic mechanisms of these phenomena. Twenty-six HIV-infected subjects were assessed over a 12-month period following the introduction of antiretroviral therapy. 18 uninfected individuals were enrolled as controls. Parameters of peripheral T-cell homeostasis (activation, maturation), gastrointestinal function (microbial translocation, gut inflammation, fecal microbiota composition) and mucosal immunity (CD4+CCR6+CD161+, CD4+CCR9+α4β7+, stem cell memory CD4+/CD8+ T-cells) were assessed. CD4+CCR6+CD161+ cells were depleted in HIV-infected untreated subjects and maintained significantly lower levels compared to controls, despite the introduction of effective antiviral treatment. The frequency of gut-homing CD4+CCR9+α4β7+ cells was also impaired in untreated infection and correlated with the HIV RNA load and CD4+HLADR+CD38+; during therapy, we observed a contraction of this pool in the peripheral blood and the loss of its correlation with antigenic exposure/immune activation. A partial correction of the balance between stem cell memory pools and T-cell homeostasis was registered following treatment. In HIV-infected subjects with moderate immune-suppression, antiretroviral therapy has a marginal impact on mucosal immune populations which feature distinctive kinetics in the periphery, possibly reflecting their diverse recruitment from the blood to the mucosa. The persistent defects in mucosal immunity may fuel peripheral T-cell abnormalities through diverse mechanisms, including the production of IL-17/IL-22, cellular permissiveness to infection and regulation of T-lymphocyte maturation. |
format | Online Article Text |
id | pubmed-6375585 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-63755852019-03-01 Mucosal cell populations may contribute to peripheral immune abnormalities in HIV-infected subjects introducing cART with moderate immune-suppression Basilissi, Matteo Tincati, Camilla Merlini, Esther Ancona, Giuseppe Borghi, Elisa Borgo, Francesca Barassi, Alessandra d’Arminio Monforte, Antonella Marchetti, Giulia PLoS One Research Article HIV infection causes the progressive depletion of CD4+ T-lymphocytes and profound modifications of T-cell homeostasis, which persist despite virologically-suppressive treatment and have been linked to a worse clinical outcome. Enduring alterations of the gastrointestinal tract may represent the underlying pathogenic mechanisms of these phenomena. Twenty-six HIV-infected subjects were assessed over a 12-month period following the introduction of antiretroviral therapy. 18 uninfected individuals were enrolled as controls. Parameters of peripheral T-cell homeostasis (activation, maturation), gastrointestinal function (microbial translocation, gut inflammation, fecal microbiota composition) and mucosal immunity (CD4+CCR6+CD161+, CD4+CCR9+α4β7+, stem cell memory CD4+/CD8+ T-cells) were assessed. CD4+CCR6+CD161+ cells were depleted in HIV-infected untreated subjects and maintained significantly lower levels compared to controls, despite the introduction of effective antiviral treatment. The frequency of gut-homing CD4+CCR9+α4β7+ cells was also impaired in untreated infection and correlated with the HIV RNA load and CD4+HLADR+CD38+; during therapy, we observed a contraction of this pool in the peripheral blood and the loss of its correlation with antigenic exposure/immune activation. A partial correction of the balance between stem cell memory pools and T-cell homeostasis was registered following treatment. In HIV-infected subjects with moderate immune-suppression, antiretroviral therapy has a marginal impact on mucosal immune populations which feature distinctive kinetics in the periphery, possibly reflecting their diverse recruitment from the blood to the mucosa. The persistent defects in mucosal immunity may fuel peripheral T-cell abnormalities through diverse mechanisms, including the production of IL-17/IL-22, cellular permissiveness to infection and regulation of T-lymphocyte maturation. Public Library of Science 2019-02-14 /pmc/articles/PMC6375585/ /pubmed/30763359 http://dx.doi.org/10.1371/journal.pone.0212075 Text en © 2019 Basilissi et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Basilissi, Matteo Tincati, Camilla Merlini, Esther Ancona, Giuseppe Borghi, Elisa Borgo, Francesca Barassi, Alessandra d’Arminio Monforte, Antonella Marchetti, Giulia Mucosal cell populations may contribute to peripheral immune abnormalities in HIV-infected subjects introducing cART with moderate immune-suppression |
title | Mucosal cell populations may contribute to peripheral immune abnormalities in HIV-infected subjects introducing cART with moderate immune-suppression |
title_full | Mucosal cell populations may contribute to peripheral immune abnormalities in HIV-infected subjects introducing cART with moderate immune-suppression |
title_fullStr | Mucosal cell populations may contribute to peripheral immune abnormalities in HIV-infected subjects introducing cART with moderate immune-suppression |
title_full_unstemmed | Mucosal cell populations may contribute to peripheral immune abnormalities in HIV-infected subjects introducing cART with moderate immune-suppression |
title_short | Mucosal cell populations may contribute to peripheral immune abnormalities in HIV-infected subjects introducing cART with moderate immune-suppression |
title_sort | mucosal cell populations may contribute to peripheral immune abnormalities in hiv-infected subjects introducing cart with moderate immune-suppression |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375585/ https://www.ncbi.nlm.nih.gov/pubmed/30763359 http://dx.doi.org/10.1371/journal.pone.0212075 |
work_keys_str_mv | AT basilissimatteo mucosalcellpopulationsmaycontributetoperipheralimmuneabnormalitiesinhivinfectedsubjectsintroducingcartwithmoderateimmunesuppression AT tincaticamilla mucosalcellpopulationsmaycontributetoperipheralimmuneabnormalitiesinhivinfectedsubjectsintroducingcartwithmoderateimmunesuppression AT merliniesther mucosalcellpopulationsmaycontributetoperipheralimmuneabnormalitiesinhivinfectedsubjectsintroducingcartwithmoderateimmunesuppression AT anconagiuseppe mucosalcellpopulationsmaycontributetoperipheralimmuneabnormalitiesinhivinfectedsubjectsintroducingcartwithmoderateimmunesuppression AT borghielisa mucosalcellpopulationsmaycontributetoperipheralimmuneabnormalitiesinhivinfectedsubjectsintroducingcartwithmoderateimmunesuppression AT borgofrancesca mucosalcellpopulationsmaycontributetoperipheralimmuneabnormalitiesinhivinfectedsubjectsintroducingcartwithmoderateimmunesuppression AT barassialessandra mucosalcellpopulationsmaycontributetoperipheralimmuneabnormalitiesinhivinfectedsubjectsintroducingcartwithmoderateimmunesuppression AT darminiomonforteantonella mucosalcellpopulationsmaycontributetoperipheralimmuneabnormalitiesinhivinfectedsubjectsintroducingcartwithmoderateimmunesuppression AT marchettigiulia mucosalcellpopulationsmaycontributetoperipheralimmuneabnormalitiesinhivinfectedsubjectsintroducingcartwithmoderateimmunesuppression |